Dr. Paner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison Street
Chicago, IL 60612Phone+1 312-942-5978
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2004 - 2007
Vilnius University Faculty of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2004 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2016 Dec 28
- A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma Start of enrollment: 2020 Feb 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 62 citationsPhase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myelomaEric K. Rowinsky, Agne Paner, Jesus G. Berdeja, Claudia E. Paba-Prada, Parameswaran Venugopal
Investigational New Drugs. 2020-03-03 - 9 citationsExercise, cancer and cardiovascular disease: what should clinicians advise?Allison Zimmerman, Maria Isabel Camara Planek, Catherine Chu, Opeyemi Oyenusi, Agne Paner
Cardiovascular Endocrinology & Metabolism. 2021-06-01 - 8 citationsPatient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner
British Journal of Haematology. 2021-10-21
Journal Articles
- The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to ActionAgne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
Abstracts/Posters
- The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Basel...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 S...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Elotuzumab Plus Pomalidomide and Dexamethasone on Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Enrolled in the ELOQUE...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
A Patient's Guide to Multiple MyelomaSeptember 25th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
